Related Announcements

RFA-CA-21-047, UG1 Clinical Research Cooperative Agreements - Single Project

Issued by

National Cancer Institute (NCI)

Purpose

This Notice informs applicants of changes to the Foreign Institutions Eligibility information in Funding Opportunity Announcement (FOA) RFA-CA-21-047, "Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)".

Effective immediately, the following section of RFA-CA-21-047, "Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)" has been modified, as indicated below.

Currently Reads:

Part 2. Section III. Eligibility Information

1. Eligible Applicants

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Modified to Read (changes shown in bold italics):

Part 2. Section III. Eligibility Information

1. Eligible Applicants

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Vikrant V. Sahasrabuddhe, M.B.B.S., Dr.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-7332
Email: [email protected]